ALL Video Channel
Explore the latest insights and summaries from experts in ALL.
Treatment Landscape
Talha Badar
Updates in ALL: Incorporating Immunotherapy in Frontline Management
- 259 views
- September 16, 2024
- 3
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Incorporation of Targeted and Immunotherapies in ALL
FEATURING
Hagop Kantarjian
- 220 views
- August 30, 2024
- 1
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Debates in Ph+ ALL: Allo-SCT Is Not Necessary Upfront in Adult Patients
FEATURING
Elias Jabbour
- 38 views
- September 6, 2024
MyCancerHaven
Treating Adults With Newly Diagnosed ALL
FEATURING
Ravi Vij,
Anand Patel
- 420 views
- April 26, 2024
- 2
Vanderbilt University Medical Center (VUMC)
Prevention and Management of Post-SCT Relapse in Acute Leukemias
FEATURING
Andrew Jallouk
- 257 views
- July 18, 2024
- 6
Insights from 2023 ASH Annual Meeting
Clinically-Relevant Updates in ALL in Adults
FEATURING
Ryan Cassaday
- 258 views
- February 20, 2024
- 1
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course
ALL in Adults: Overview and Recent Advances
FEATURING
Ryan Cassaday
- 231 views
- August 13, 2024
- 2
Indy Hematology Review
Treatment Strategies in MDS and ALL: Removing Bad Humor & Targeting Aberrant Signaling
FEATURING
Richard Stone
- 183 views
- April 22, 2024
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Immunotherapies in Acute Leukemias: 2024 Update
FEATURING
Catherine Lai
- 536 views
- March 11, 2024
- 3
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Will Immune Therapy Replace Transplant in Hematologic Malignancies?
FEATURING
Robert Peter Gale
- 509 views
- February 21, 2024
- 2
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: ALL
FEATURING
Elias Jabbour
- 203 views
- March 29, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in Heme Malignancies
FEATURING
Maria Gomes da Silva
- 456 views
- September 23, 2024
- 2
Yale Cancer Center
Summary of Recent Advances in Adult ALL
FEATURING
Lourdes Mendez
- 137 views
- May 15, 2024
SOHO Brazil 2024
How Are Targeted Therapies Redefining the Treatment Paradigm in ALL in Adults
FEATURING
Jan Burger
- 127 views
- July 11, 2024
- 1
MyCancerHaven
Incorporating Blinatumomab and Inotuzumab Into 1L ALL Treatment
FEATURING
Ravi Vij,
Nicholas Short
- 153 views
- August 30, 2024
- 2
Louisville Hematology Highlights
Current Approaches in the Frontline Treatment of Adult ALL
FEATURING
Nicholas Short
- 149 views
- February 26, 2024
Rush University Medical Center
Cellular Therapy Strategies for Persistent Disease After Induction for B-ALL
FEATURING
Vinod Pullarkat
- 51 views
- May 29, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
How I Manage Febrile Neutropenia in Patients With Cancer
FEATURING
Şiran Keske
- 65 views
- February 21, 2024
- 1
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Best of ASCO® 2024: CML, AML, ALL
FEATURING
Mariam Nawas
- 41 views
- September 3, 2024
Moffitt Cancer Center
Hot Off the Press: Experts Discuss the Latest Data in Lymphoid Diseases
- 46 views
- March 11, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Debates in Ph+ ALL: Allo-SCT Should Be Used Upfront in Adult Patients
FEATURING
Dieter Hoelzer
- 27 views
- September 6, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Is HSCT Necessary to Consolidate Hematological Remission After CAR-T in ALL?
FEATURING
Francesco Saglio
- 43 views
- February 16, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Management of Persistently MRD+ ALL
FEATURING
Asli Odabasi Giden
- 32 views
- August 15, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Current and Future Approaches to the Treatment of B- and T-ALL
FEATURING
Dieter Hoelzer
- 31 views
- February 16, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Adults With ALL: When Not to Transplant
FEATURING
Elias Jabbour
- 36 views
- February 15, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Recent Updates in ALL Treatment
FEATURING
Giovanni Martinelli
- 21 views
- February 15, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Current Approaches to Managing T-Cell ALL
FEATURING
Ahmad Ibrahim
- 20 views
- August 28, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Feasibilty of Therapy for Elderly Ph+ ALL Patients
FEATURING
Giovanni Marconi
- 24 views
- February 15, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
HSCT Post CAR-T in Hematologic Malignancies: To Transplant or Not to Transplant
FEATURING
Koray YalçIn
- 20 views
- February 16, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Adults With ALL: When to Transplant
FEATURING
Sabina Chiaretti
- 19 views
- February 15, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Induction Therapy Choices and Responses of ALL in a Third World Country: A Single-Center Study From Pakistan
FEATURING
Amjad Zafar
- 16 views
- February 16, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Molecular Characteristics and Treatment Response to COG-ALL Protocols in Pediatric Patients
FEATURING
Bengisu GüNer Yılmaz
- 8 views
- February 16, 2024